Albert Cha, Director at ProNAi Therapeutics Inc (DNAI), bought 2,393,279 shares at $17.00 ($4.3M) on 2015-07-21, disclosed to the SEC on 2015-07-21.
Open-market purchase of $4.3M DNAI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,064,308 | $0 | 0.0% |
| 2 | $5.22 | 2,324 | $12K | 0.3% |
| 3 | $5.22 | 106,647 | $557K | 12.9% |
| 4 | $17.00 | 4,693 | $80K | 1.9% |
| 5 | $17.00 | 215,307 | $3.7M | 84.9% |
| Total | $1.80 avg | 2,393,279 |
| $4.3M |
| 100% |
| Filing → |
| KALV | BUY | 2019-07-30 | $1.9M | — | Filing → |
| KALV | BUY | 2019-07-19 | $2.2M | — | Filing → |
| KALV | BUY | 2018-09-12 | $18.0M | — | Filing → |